Brind.
  1. Veracyte and Transmedics operate within the same molecular diagnostic industry.
  2. The removal of Triumph Group impacted market sentiment on July 26, 2025, affecting companies like Veracyte.

Triumph Group was replaced in the index on July 25, 2025, while Veracyte joined, amid acquisition plans by Warburg Pincus and Berkshire Partners.

1 report, 1 independent Updated Jul 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Triumph Group was replaced in the index on July 25, 2025, while Veracyte joined, amid acquisition plans by Warburg Pincus and Berkshire Partners.

Who's involved

What this event is mainly about
Warburg PincusTriumphVeracyte (United States)

Keep exploring

Part of

The removal of Triumph Group impacted market sentiment on July 26, 2025, affecting companies like Veracyte. All 1 developments

Within Veracyte and Transmedics operate within the same molecular diagnostic industry.

The entities involved

Coverage

Newest first; wire copies grouped
  • PR NewswireVeracyte Set to Join S&P SmallCap 600 NEW YORK, July 24, 2025 /PRNewswire/ -- Veracyte Inc. (NASD: VCYT) will replace Triumph Group Inc. (NYSE: TGI) in the S&P SmallCap 600 effective prior to the ope